Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6588542 | 1.00 | KDM4E (0.36) | KDM4ELMNACYP2C19 | |
| SCHEMBL339491 | 1.00 | — | — | |
| SCHEMBL597791 | 0.97 | — | — | |
| SCHEMBL2289717 | 0.90 | — | — | |
| SCHEMBL8485857 | 0.87 | KDM4E (0.30) | KDM4ELMNACYP2C19 | |
| SCHEMBL23656219 | 0.84 | — | — | |
| SCHEMBL20104743 | 0.83 | — | — | |
| SCHEMBL5756962 | 0.82 | — | — | |
| SCHEMBL613348 | 0.82 | — | — | |
| SCHEMBL23656234 | 0.81 | KDM4E (0.30) | KDM4ELMNACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10781149-B2 | Transalkylation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-09-22 | — | — | US | claimed |
| US-20160176787-A1 | Transalkylation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-06-23 | — | — | US | claimed |
| US-10781149-B2 | Transalkylation process | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-09-22 | — | — | US | disclosed |
| US-20160176787-A1 | Transalkylation Process | EXXONMOBIL CHEMICAL PATENTS INC. | 2016-06-23 | — | — | US | disclosed |
| EP-0823423-B1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMA CO LTD (JP) | 2004-06-16 | — | — | EP | disclosed |
| US-6140338-A | FOR TREATING ACUTE INFLAMMATORY DISEASES, CHRONIC INFLAMMATORY DISEASES, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, ISCHEMIC REFLOW DISORDER AND/OR ARTERIOSCLEROSIS | BANYU PHARMACEUTICAL, CO., LTD. (JP) | 2000-10-31 | — | — | US | disclosed |
| US-6040449-A | USEFUL FOR FORMING FLUORINE CONTAINING 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES, USEFUL AS ANTAGONIST FOR MUSCARINIC M3 RECEPTORS AND LESS SIDE EFFECT | BANYU PHARMACEUTICAL CO LTD (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5948792-A | POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0930298-A1 | FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-07-21 | — | — | EP | disclosed |
| EP-0916668-A1 | CHEMOKINE RECEPTOR ANTAGONISTS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1999-05-19 | — | — | EP | disclosed |
| US-5814654-A | TREATMENT OF HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS, ORGAN DISORDERS ASSOCIATED WITH ISCHEMIA, CEREBRO-ISCHEMIC DISORDERS, CELL PROLIFERATION, ENDOTHELIAL CELL INJURY | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-09-29 | — | — | US | disclosed |
| US-5750540-A | SIDE EFFECT REDUCTION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-05-12 | — | — | US | disclosed |
| EP-0823423-A1 | 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0606898-B1 | Injection of antifoulants into thermal cracking reactors | PHILLIPS PETROLEUM CO (US) | 1997-08-27 | — | — | EP | disclosed |
| EP-0606898-A1 | Injection of antifoulants into thermal cracking reactors | PHILLIPS PETROLEUM COMPANY (US) | 1994-07-20 | — | — | EP | disclosed |
| US-5284994-A | Injection of antifoulants into thermal cracking reactors | PHILLIPS PETROLEUM COMPANY (US) | 1994-02-08 | — | — | US | disclosed |